Spots Global Cancer Trial Database for tyrosinase peptide
Every month we try and update this database with for tyrosinase peptide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma | NCT00003222 | Melanoma (Skin) | aldesleukin gp100 antigen incomplete Freu... sargramostim tetanus peptide... tyrosinase pept... | 18 Years - 79 Years | University of Virginia | |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal | NCT00003229 | Melanoma (Skin) | aldesleukin gp100 antigen tyrosinase pept... | 18 Years - 75 Years | Duke University | |
| Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma | NCT00006385 | Melanoma (Skin) | MART-1 antigen gp100 antigen incomplete Freu... recombinant int... sargramostim tyrosinase pept... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma | NCT00003792 | Melanoma (Skin) | MART-1 antigen filgrastim flu matrix pept... gp100 antigen recombinant MAG... tyrosinase pept... in vitro-treate... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Melanoma | NCT00020358 | Melanoma (Skin) | aldesleukin gp100 antigen incomplete Freu... tyrosinase pept... | 16 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Melanoma | NCT00020358 | Melanoma (Skin) | aldesleukin gp100 antigen incomplete Freu... tyrosinase pept... | 16 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma | NCT00003362 | Melanoma (Skin) | QS21 gp100 antigen incomplete Freu... sargramostim tyrosinase pept... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal | NCT00003229 | Melanoma (Skin) | aldesleukin gp100 antigen tyrosinase pept... | 18 Years - 75 Years | Duke University | |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma | NCT00037037 | Melanoma (Skin) | MAGE-10.A2 MART-1 antigen NY-ESO-1 peptid... sargramostim tyrosinase pept... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma | NCT00003222 | Melanoma (Skin) | aldesleukin gp100 antigen incomplete Freu... sargramostim tetanus peptide... tyrosinase pept... | 18 Years - 79 Years | University of Virginia | |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma | NCT00003665 | Melanoma (Skin) | dendritic cell-... gp100 antigen therapeutic tum... tyrosinase pept... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00006113 | Melanoma (Skin) | MART-1 antigen aldesleukin gp100 antigen recombinant CD4... recombinant int... recombinant int... sargramostim therapeutic aut... therapeutic tum... tyrosinase pept... Candida albican... | 18 Years - | University of Southern California | |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma | NCT00003792 | Melanoma (Skin) | MART-1 antigen filgrastim flu matrix pept... gp100 antigen recombinant MAG... tyrosinase pept... in vitro-treate... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma | NCT00019383 | Melanoma (Skin) | aldesleukin incomplete Freu... sargramostim tyrosinase pept... tyrosinase-rela... | 16 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
